Access to vaccine technologies in developing countries: Brazil and India

Area of Science:

• Pharmaceutical Sciences
• Biotechnology
• Global Health

Background:

• Developing countries face challenges in accessing innovative vaccine technologies.
• Brazil and India are key players in vaccine manufacturing and access.

Purpose of the Study:

• To analyze technology access strategies for innovative vaccines in Brazil and India.
• To evaluate the advantages and disadvantages of different technology acquisition methods.
• To assess the impact of intellectual property management on vaccine development.

Main Methods:

• Qualitative study involving site visits and interviews with vaccine manufacturers.
• Comprehensive literature search on vaccine technology transfer and intellectual property.
• Illustrative case study on a new combination vaccine development.

Main Results:

• Manufacturers utilize collaborations, technology transfer, public sector partnerships, and importation.
• Each access strategy presents distinct trade-offs regarding speed, market access, and production independence.
• Concerns regarding patent infringement and intellectual property landscape mastery are prevalent.

Conclusions:

• Effective intellectual property management is vital for successful vaccine development and market entry.
• The long-term effects of TRIPS (Trade-Related Aspects of Intellectual Property Rights) on vaccine technology access require further monitoring.
• Strategic technology acquisition is key for enhancing vaccine production capabilities in emerging economies.